Figure - available from: Pharmacogenomics and Personalized Medicine
This content is subject to copyright. Terms and conditions apply.
Expression and prognostic values of PSMC2 in pan-cancer. (A) The level of PSMC2 expression in different tumor types from the TCGA and the GTEx database. Note: “*” indicates statistical significance. (B and C) Kaplan-Meier analysis showed survival curves of OS and progression free survival (PFS) in patients with low and high PSMC2 expression in pan-cancer. (D and E) Forest plot showing the prognostic values of PSMC2 in terms of OS and PFS in different cancer types.
Source publication
Background
Proteasome 26S subunit ATPase 2 (PSMC2) is a part of the 19S regulatory complex, which catalyzes the unfolding and transport of substrates into the 20S proteasome. Our previous research demonstrated that PSMC2 participates in the tumorigenesis and progression of pancreatic cancer (PC). However, no systematic analysis has been conducted t...
Similar publications
The ubiquitin–proteasome system (UPS) is an essential regulatory system for maintaining homeostasis, and its dysfunction may cause various diseases. The activity of proteasome and ubiquitin-conjugating enzymes has been found to be greatly increased in breast cancer (BC), indicating that the heterogeneity of UPS may be related to the progression of...
